Mutual of America Capital Management LLC Raises Position in HealthEquity, Inc. (NASDAQ:HQY)

Mutual of America Capital Management LLC grew its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 0.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 97,070 shares of the company’s stock after purchasing an additional 355 shares during the period. Mutual of America Capital Management LLC owned approximately 0.11% of HealthEquity worth $8,367,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HQY. Motley Fool Asset Management LLC increased its position in shares of HealthEquity by 3,001.0% in the 1st quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock valued at $307,097,000 after acquiring an additional 3,640,748 shares during the period. Norges Bank acquired a new position in shares of HealthEquity in the 4th quarter valued at $43,482,000. Vaughan Nelson Investment Management L.P. acquired a new position in shares of HealthEquity in the 1st quarter valued at $49,443,000. Wasatch Advisors LP increased its position in shares of HealthEquity by 8.3% in the 1st quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock valued at $604,803,000 after acquiring an additional 569,249 shares during the period. Finally, Generate Investment Management Ltd acquired a new position in shares of HealthEquity in the 2nd quarter valued at $24,184,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

NASDAQ:HQY opened at $77.54 on Thursday. The stock has a market capitalization of $6.75 billion, a PE ratio of 84.28, a price-to-earnings-growth ratio of 1.19 and a beta of 0.52. HealthEquity, Inc. has a 52 week low of $61.81 and a 52 week high of $88.26. The stock’s 50-day moving average price is $76.08 and its 200-day moving average price is $79.37. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51.

Insider Activity at HealthEquity

In related news, CEO Jon Kessler sold 32,326 shares of the firm’s stock in a transaction dated Monday, June 24th. The shares were sold at an average price of $82.83, for a total value of $2,677,562.58. Following the transaction, the chief executive officer now directly owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, Vice Chairman Stephen Neeleman sold 35,000 shares of the firm’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the transaction, the insider now directly owns 89,769 shares of the company’s stock, valued at approximately $7,168,952.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jon Kessler sold 32,326 shares of the firm’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the transaction, the chief executive officer now directly owns 232,176 shares in the company, valued at $19,231,138.08. The disclosure for this sale can be found here. In the last three months, insiders have sold 75,031 shares of company stock valued at $6,103,625. 2.20% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have weighed in on HQY. Barrington Research reaffirmed an “outperform” rating and set a $105.00 price target on shares of HealthEquity in a research report on Friday, August 30th. Raymond James increased their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th. Wells Fargo & Company increased their price target on HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a research report on Thursday, June 20th. Bank of America cut their price target on HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and an average price target of $103.83.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.